BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thiele S, Hannemann A, Winzer M, Baschant U, Weidner H, Nauck M, Thakker RV, Bornhäuser M, Hofbauer LC, Rauner M. Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans. Endocr Connect 2019;8:923-34. [PMID: 31234141 DOI: 10.1530/EC-19-0104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gado M, Baschant U, Hofbauer LC, Henneicke H. Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes. Front Endocrinol 2022;13:835720. [DOI: 10.3389/fendo.2022.835720] [Reference Citation Analysis]
2 Mochizuki T, Yano K, Ikari K, Okazaki K. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study. Osteoporos Sarcopenia 2021;7:110-4. [PMID: 34632114 DOI: 10.1016/j.afos.2021.08.001] [Reference Citation Analysis]
3 Vasiliadis ES, Evangelopoulos DS, Kaspiris A, Benetos IS, Vlachos C, Pneumaticos SG. The Role of Sclerostin in Bone Diseases. J Clin Med 2022;11:806. [PMID: 35160258 DOI: 10.3390/jcm11030806] [Reference Citation Analysis]
4 Golledge J, Thanigaimani S. Role of Sclerostin in Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2022;42:e187-202. [PMID: 35546488 DOI: 10.1161/ATVBAHA.122.317635] [Reference Citation Analysis]
5 Gao J, Xiang S, Wei X, Yadav RI, Han M, Zheng W, Zhao L, Shi Y, Cao Y. Icariin Promotes the Osteogenesis of Bone Marrow Mesenchymal Stem Cells through Regulating Sclerostin and Activating the Wnt/β-Catenin Signaling Pathway. Biomed Res Int 2021;2021:6666836. [PMID: 33553429 DOI: 10.1155/2021/6666836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fassio A, Adami G, Idolazzi L, Giollo A, Viapiana O, Vantaggiato E, Benini C, Rossini M, Dejaco C, Gatti D. Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment. Front Med (Lausanne) 2020;7:551. [PMID: 33015101 DOI: 10.3389/fmed.2020.00551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Peng CH, Lin WY, Yeh KT, Chen IH, Wu WT, Lin MD. The molecular etiology and treatment of glucocorticoid-induced osteoporosis. Tzu Chi Med J 2021;33:212-23. [PMID: 34386357 DOI: 10.4103/tcmj.tcmj_233_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]